ストックスクリーナーアプリを入手
4.00
7.82%
0.29
アフターアワーズ：
3.92
-0.08
-2.00%
前日終値:
$3.71
開ける：
$3.75
24時間の取引高:
184.27K
Relative Volume:
1.07
時価総額：
$245.23M
収益：
$45.15M
当期純損益:
$-39.23M
株価収益率:
-2.187
EPS:
-1.829
ネットキャッシュフロー:
$-18.93M
1週間 パフォーマンス:
+2.83%
1か月 パフォーマンス:
-20.95%
6か月 パフォーマンス:
-13.98%
1年 パフォーマンス:
-27.54%
1日の値動き範囲:
$3.73
$4.02
1週間の範囲:
$3.61
$4.09
52週間の値動き範囲:
$3.42
$7.95
Trisalus Life Sciences Inc Stock (TLSI) Company Profile
名前
Trisalus Life Sciences Inc
セクター
電話
415 336 8917
住所
6272 WEST 91ST AVENUE, WESTMINSTER
Compare TLSI vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TLSI
Trisalus Life Sciences Inc
|
4.00 | 227.45M | 45.15M | -39.23M | -18.93M | -1.829 |
ABT
Abbott Laboratories
|
102.67 | 177.03B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
328.59 | 124.89B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.65 | 110.08B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.75 | 93.53B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
80.08 | 45.84B | 6.07B | 1.06B | 1.34B | 1.8063 |
Trisalus Life Sciences Inc Stock (TLSI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-13 | 開始されました | Lake Street | Buy |
| 2024-12-17 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-11-11 | 開始されました | ROTH MKM | Buy |
| 2024-10-25 | 開始されました | Northland Capital | Outperform |
| 2024-09-16 | 開始されました | Oppenheimer | Outperform |
| 2024-05-30 | 開始されました | Canaccord Genuity | Buy |
すべてを表示
Trisalus Life Sciences Inc (TLSI) 最新ニュース
Revenue Check: Why is TriSalus Life Sciences Inc stock going up2026 Key Highlights & Entry Point Confirmation Signals - baoquankhu1.vn
Aug PreEarnings: Is TriSalus Life Sciences Inc Equity Warrant in a long term uptrend2026 Market Mood & Technical Buy Zone Confirmation - baoquankhu1.vn
Executive pay and board elections at TriSalus (TLSI) 2026 virtual shareholder meeting - Stock Titan
Aug PreEarnings: Is TriSalus Life Sciences Inc Equity Warrants growth already priced inDip Buying & Weekly Top Performers Watchlists - baoquankhu1.vn
Published on: 2026-03-26 07:22:01 - baoquankhu1.vn
Momentum Shift: Does TriSalus Life Sciences Inc have pricing power2026 Top Gainers & Technical Confirmation Alerts - baoquankhu1.vn
What is Northland Securities' Estimate for TLSI Q1 Earnings? - MarketBeat
Insider Selling: TriSalus Life Sciences (NASDAQ:TLSI) CEO Sells $17,998.54 in Stock - Defense World
Insider Selling: TriSalus Life Sciences (NASDAQ:TLSI) CEO Sells $61,384.40 in Stock - Defense World
Weekly Earnings: Can TriSalus Life Sciences Inc Equity Warrant keep up with sector leadersMarket Risk Analysis & Fast Exit and Entry Trade Guides - baoquankhu1.vn
TriSalus Life Sciences launches proposed public stock offering - MSN
Aug Movers: Is TriSalus Life Sciences Inc Equity Warrant a top pick in the sector2026 Price Targets & Community Consensus Trade Signals - baoquankhu1.vn
RSI Check: Is TriSalus Life Sciences Inc Equity Warrant forming a bullish divergenceMarket Volume Summary & AI Powered Market Trend Analysis - baoquankhu1.vn
Top TriSalus Executives Make Major Moves With Insider Stock Sales - TipRanks
TriSalus Life Sciences (NASDAQ:TLSI) CEO Sells $17,998.54 in Stock - MarketBeat
TriSalus Life Sciences (NASDAQ:TLSI) CEO Sells $61,384.40 in Stock - MarketBeat
Szela, CEO of TriSalus, sells $79k in TLSI stock By Investing.com - Investing.com India
Szela, CEO of TriSalus, sells $79k in TLSI stock - Investing.com
TriSalus Life Sciences (TLSI) chief regulatory officer sells $14509 in stock - Investing.com
Trisalus Life Sciences’ CCO Marshak sells $14k in TLSI stock - Investing.com UK
Devlin Jodi, TriSalus Life Sciences chief, sells $13k in TLSI stock By Investing.com - Investing.com South Africa
Devlin Jodi, TriSalus Life Sciences chief, sells $13k in TLSI stock - Investing.com
TriSalus Life Sciences chief of research Cox sells $13k in TLSI stock - Investing.com
TriSalus (TLSI) executive sells 3,207 shares to satisfy RSU tax withholding - Stock Titan
TriSalus (TLSI) Chief of Research has 3,184 shares sold for tax withholding - Stock Titan
TriSalus (TLSI) CCO logs small tax-related share disposals, retains over 110K shares - Stock Titan
TriSalus Life Sciences (TLSI) CRO sells shares for taxes - Stock Titan
TriSalus (TLSI) CEO Szela disposes 20,302 shares for tax withholding - Stock Titan
TriSalus publishes preclinical data on drug delivery technology By Investing.com - Investing.com South Africa
Should I invest in TriSalus Life Sciences Inc before earningsWall Street Watch & Technical Buy Zone Confirmations - baoquankhu1.vn
TriSalus publishes preclinical data on drug delivery technology - Investing.com
Animal study from TriSalus pumps more immune drug into liver tumors in models - Stock Titan
Update Recap: What is the dividend yield of TriSalus Life Sciences Inc Equity WarrantRate Hike & Precise Entry and Exit Recommendations - baoquankhu1.vn
Published on: 2026-03-18 18:04:21 - baoquankhu1.vn
Analysis Recap: Is TriSalus Life Sciences Inc Equity Warrant benefiting from innovation trends2026 Key Lessons & Capital Efficiency Focused Ideas - baoquankhu1.vn
Canaccord lowers its price target on TriSalus Life Sciences, Inc. (TLSI) to $7 from $12 and maintains a buy rating - MSN
Canaccord Lowers its Price Target on TriSalus Life Sciences, Inc. (TLSI) to $7 from $12 and Maintains a Buy Rating - Insider Monkey
Analysts Offer Insights on Healthcare Companies: TriSalus Life Sciences (TLSI), Cullinan Management (CGEM) and Pfizer (PFE) - The Globe and Mail
TriSalus Life Sciences Signals Confident Growth Path - TipRanks
11 Fastest Growing Penny Stocks to Buy Right Now - Insider Monkey
TLSIW Stock Price, News & Analysis - Stock Titan
Research Analysts Issue Forecasts for TLSI Q1 Earnings - MarketBeat
Canaccord Genuity Group Has Lowered Expectations for TriSalus Life Sciences (NASDAQ:TLSI) Stock Price - Defense World
TriSalus Life Sciences (NASDAQ:TLSI) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Canaccord Genuity Group Issues Pessimistic Forecast for TriSalus Life Sciences (NASDAQ:TLSI) Stock Price - MarketBeat
Jones Trading reiterates Buy on TriSalus Life Sciences stock after earnings By Investing.com - Investing.com South Africa
Jones Trading reiterates Buy on TriSalus Life Sciences stock after earnings - Investing.com
TriSalus Life Sciences Q4 Earnings Call Highlights - Yahoo Finance
Boston Scientific to buy Penumbra in $14.5 billion deal - AOL.com
TriSalus Life Sciences reaffirms $60M–$62M revenue guidance for 2026 while expanding PEDD portfolio - MSN
Earnings call transcript: TriSalus Life Sciences sees 60% Q4 revenue rise - Investing.com
Trisalus Life Sciences Inc (TLSI) 財務データ
収益
当期純利益
現金流量
EPS
Trisalus Life Sciences Inc (TLSI) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Devlin Jodi | Chief of Clinical Operations |
Mar 11 '26 |
Sale |
4.13 |
1,162 |
4,799 |
99,409 |
| Devlin Jodi | Chief of Clinical Operations |
Mar 16 '26 |
Sale |
4.12 |
273 |
1,125 |
97,364 |
| Cox Bryan F. | Chief of Research |
Mar 12 '26 |
Sale |
4.09 |
1,467 |
6,000 |
163,994 |
| Cox Bryan F. | Chief of Research |
Mar 11 '26 |
Sale |
4.13 |
1,138 |
4,700 |
165,461 |
| Cox Bryan F. | Chief of Research |
Mar 16 '26 |
Sale |
4.12 |
579 |
2,385 |
163,415 |
| Marshak Richard | Chief Commercial Officer |
Mar 12 '26 |
Sale |
4.09 |
1,589 |
6,499 |
110,816 |
| Marshak Richard | Chief Commercial Officer |
Mar 11 '26 |
Sale |
4.13 |
1,449 |
5,984 |
112,405 |
| Marshak Richard | Chief Commercial Officer |
Mar 16 '26 |
Sale |
4.12 |
419 |
1,726 |
110,397 |
| Stevens Jennifer | Chief Regulatory Officer |
Mar 12 '26 |
Sale |
4.09 |
1,552 |
6,348 |
124,884 |
| Stevens Jennifer | Chief Regulatory Officer |
Mar 11 '26 |
Sale |
4.13 |
1,204 |
4,973 |
126,436 |
2.03%
大文字化:
|
ボリューム (24 時間):